This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations | MicrobiomeTrials
← Back to trials NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-04-11Est. Completion: 2029-12-28
Enrollment target: 675 participantsLocations Research Site, Anchorage, Alaska, United States Research Site, Tucson, Arizona, United States Research Site, Little Rock, Arkansas, United States Research Site, Springdale, Arkansas, United States Research Site, Anaheim, California, United States Research Site, Beverly Hills, California, United States Research Site, Fountain Valley, California, United States Research Site, Newport Beach, California, United States Research Site, Clermont, Florida, United States Research Site, Gainesville, Florida, United States Research Site, Miami Beach, Florida, United States Research Site, Orange City, Florida, United States Research Site, Orlando, Florida, United States Research Site, Orlando, Florida, United States Research Site, West Palm Beach, Florida, United States Research Site, Atlanta, Georgia, United States Research Site, Atlanta, Georgia, United States Research Site, Atlanta, Georgia, United States Other microbiome trials you might be interested in Advanced/Metastatic Non-Small Cell Lung Cancer
This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metas…
Goodyear, United States Est. completion Jun 24, 2030
Advanced Lung Non-Squamous Non-Small Cell Carcinoma Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Stage IIIB Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…
Research Site, Atlanta, Georgia, United States
Research Site, Hinsdale, Illinois, United States
Research Site, Noblesville, Indiana, United States
Research Site, Paducah, Kentucky, United States
Research Site, Annapolis, Maryland, United States
Research Site, Boston, Massachusetts, United States
Research Site, Boston, Massachusetts, United States
Research Site, Dearborn, Michigan, United States
Research Site, Farmington Hills, Michigan, United States
Research Site, Grand Rapids, Michigan, United States
Research Site, Traverse City, Michigan, United States
Research Site, Hattiesburg, Mississippi, United States
Research Site, Kansas City, Missouri, United States
Research Site, Bozeman, Montana, United States
Research Site, Grand Island, Nebraska, United States
Research Site, Omaha, Nebraska, United States
Research Site, Las Vegas, Nevada, United States
Research Site, Reno, Nevada, United States
Research Site, Voorhees Township, New Jersey, United States
Research Site, Stony Brook, New York, United States
Research Site, Greenville, North Carolina, United States
Research Site, Salisbury, North Carolina, United States
Research Site, Cincinnati, Ohio, United States
Research Site, Columbus, Ohio, United States
Research Site, Maumee, Ohio, United States
Research Site, Toledo, Ohio, United States
Research Site, Portland, Oregon, United States
Research Site, Greenville, South Carolina, United States
Research Site, Sioux Falls, South Dakota, United States
Research Site, Chattanooga, Tennessee, United States
Research Site, Knoxville, Tennessee, United States
Research Site, Fort Worth, Texas, United States
Research Site, Houston, Texas, United States
Research Site, Houston, Texas, United States
Research Site, Houston, Texas, United States
Research Site, Kingwood, Texas, United States
Research Site, Odessa, Texas, United States
Research Site, Fort Belvoir, Virginia, United States
Research Site, Leesburg, Virginia, United States
Research Site, Midlothian, Virginia, United States
Research Site, Richmond, Virginia, United States
Research Site, Tacoma, Washington, United States
Research Site, Vancouver, Washington, United States
Research Site, Wenatchee, Washington, United States
Research Site, Appleton, Wisconsin, United States
Research Site, Birtinya, Australia
Research Site, Blacktown, Australia
Research Site, Clayton, Australia
Research Site, Gosford, Australia
Research Site, Melbourne, Australia
Research Site, South Brisbane, Australia
Research Site, Wodonga, Australia
Research Site, Innsbruck, Austria
Research Site, Krems, Austria
Research Site, Linz, Austria
Research Site, Rankweil, Austria
Research Site, Vienna, Austria
Research Site, Vienna, Austria
Research Site, Wels, Austria
Research Site, Anderlecht, Belgium
Research Site, Bruges, Belgium
Research Site, Hasselt, Belgium
Research Site, La Louvière, Belgium
Research Site, Liège, Belgium
Research Site, Barretos, Brazil
Research Site, Curitiba, Brazil
Research Site, Florianópolis, Brazil
Research Site, Ipatinga, Brazil
Research Site, Natal, Brazil
Research Site, Porto Alegre, Brazil
Research Site, Rio de Janeiro, Brazil
Research Site, Santa Maria, Brazil
Research Site, São Paulo, Brazil
Research Site, Taubaté, Brazil
Research Site, Vancouver, British Columbia, Canada
Research Site, Winnipeg, Manitoba, Canada
Research Site, St. John's, Newfoundland and Labrador, Canada
Research Site, London, Ontario, Canada
Research Site, Newmarket, Ontario, Canada
Research Site, Oshawa, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Lévis, Quebec, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Rimouski, Quebec, Canada
Research Site, Trois-Rivières, Quebec, Canada
Research Site, Saskatoon, Saskatchewan, Canada
Research Site, Chicoutimi, Canada
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Changchun, China
Research Site, Changsha, China
Research Site, Chengdu, China
Research Site, Chengdu, China
Research Site, Chongqing, China
Research Site, Fuzhou, China
Research Site, Guangzhou, China
Research Site, Hangzhou, China
Research Site, Hangzhou, China
Research Site, Hangzhou, China
Research Site, Harbin, China
Research Site, Hefei, China
Research Site, Hefei, China
Research Site, Jinan, China
Research Site, Jining, China
Research Site, Kunming, China
Research Site, Lanzhou, China
Research Site, Linhai, China
Research Site, Linyi, China
Research Site, Nanjing, China
Research Site, Nanning, China
Research Site, Nanning, China
Research Site, Shanghai, China
Research Site, Shanghai, China
Research Site, Shanghai, China
Research Site, Shenyang, China
Research Site, Taiyuan, China
Research Site, Tianjin, China
Research Site, Wenzhou, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Xi'an, China
Research Site, Yangzhou, China
Research Site, Zhengzhou, China
Research Site, Zhengzhou, China
Research Site, Berlin, Germany
Research Site, Bonn, Germany
Research Site, Cologne, Germany
Research Site, Düsseldorf, Germany
Research Site, Essen, Germany
Research Site, Freiburg im Breisgau, Germany
Research Site, Gauting, Germany
Research Site, Georgsmarienhütte, Germany
Research Site, Gera, Germany
Research Site, Gütersloh, Germany
Research Site, Hamburg, Germany
Research Site, Hamburg, Germany
Research Site, Heidelberg, Germany
Research Site, Kempten, Germany
Research Site, Koblenz, Germany
Research Site, Ludwigsburg, Germany
Research Site, München, Germany
Research Site, Nuremberg, Germany
Research Site, Potsdam, Germany
Research Site, Ravensburg, Germany
Research Site, Budapest, Hungary
Research Site, Gyöngyös, Hungary
Research Site, Gyöngyös - Mátraháza, Hungary
Research Site, Győr, Hungary
Research Site, Gyula, Hungary
Research Site, Kecskemét, Hungary
Research Site, Salgótarján, Hungary
Research Site, Szekszárd, Hungary
Research Site, Székesfehérvár, Hungary
Research Site, Szolnok, Hungary
Research Site, Törökbálint, Hungary
Research Site, Chennai, India
Research Site, Dwārka, India
Research Site, Jaipur, India
Research Site, Kolkata, India
Research Site, Marg Jaipur, India
Research Site, Nagpur, India
Research Site, Nashik, India
Research Site, New Delhi, India
Research Site, New Delhi, India
Research Site, Surat, India
Research Site, Thiruvananthapuram, India
Research Site, Bergamo, Italy
Research Site, Genoa, Italy
Research Site, Milan, Italy
Research Site, Milan, Italy
Research Site, Monza, Italy
Research Site, Padova, Italy
Research Site, Pavia, Italy
Research Site, Ravenna, Italy
Research Site, Roma, Italy
Research Site, Rozzano, Italy
Research Site, Bunkyō City, Japan
Research Site, Bunkyō City, Japan
Research Site, Fukuoka, Japan
Research Site, Fukuoka, Japan
Research Site, Hidaka-shi, Japan
Research Site, Hirakata-shi, Japan
Research Site, Hirosaki-shi, Japan
Research Site, Hiroshima, Japan
Research Site, Kanazawa, Japan
Research Site, Kashiwa, Japan
Research Site, Kawasaki-shi, Japan
Research Site, Kumamoto, Japan
Research Site, Matsusaka-shi, Japan
Research Site, Nagoya, Japan
Research Site, Niigata, Japan
Research Site, Okayama, Japan
Research Site, Osaka, Japan
Research Site, Osakasayama-shi, Japan
Research Site, Sagamihara-shi, Japan
Research Site, Sapporo, Japan
Research Site, Takaoka-shi, Japan
Research Site, Takatsuki-shi, Japan
Research Site, Tokushima, Japan
Research Site, Tokyo, Japan
Research Site, Utsunomiya, Japan
Research Site, Yokohama, Japan
Research Site, Olsztyn, Poland
Research Site, Poznan, Poland
Research Site, Przemyśl, Poland
Research Site, Warsaw, Poland
Research Site, Warsaw, Poland
Research Site, San Juan, Puerto Rico
Research Site, Changwon, South Korea
Research Site, Incheon, South Korea
Research Site, Seongnam-si, South Korea
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, Suwon, South Korea
Research Site, Suwon, South Korea
Research Site, Alicante, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Jerez de la Frontera, Spain
Research Site, Reus, Spain
Research Site, Salamanca, Spain
Research Site, Kaohsiung City, Taiwan
Research Site, New Taipei City, Taiwan
Research Site, Taichung, Taiwan
Research Site, Taichung, Taiwan
Research Site, Tainan, Taiwan
Research Site, Taipei, Taiwan
Research Site, Taipei, Taiwan
Research Site, Taipei, Taiwan
Research Site, Taipei, Taiwan
Research Site, Taoyuan, Taiwan
Research Site, Bangkok, Thailand
Research Site, Hat Yai, Thailand
Research Site, Muang, Thailand
Research Site, Mueang, Thailand
Research Site, Mueang, Thailand
Research Site, Adapazarı, Turkey (Türkiye)
Research Site, Ankara, Turkey (Türkiye)
Research Site, Ankara, Turkey (Türkiye)
Research Site, Antalya, Turkey (Türkiye)
Research Site, Diyarbakır, Turkey (Türkiye)
Research Site, Istanbul, Turkey (Türkiye)
Research Site, Istanbul, Turkey (Türkiye)
Research Site, Cheltenham, United Kingdom
Research Site, Inverness, United Kingdom
Research Site, London, United Kingdom
Research Site, London, United Kingdom
Research Site, London, United Kingdom
Research Site, Norwich, United Kingdom
Research Site, Preston, United Kingdom
Research Site, Truro, United Kingdom
Research Site, Da Nang, Vietnam
Research Site, Hanoi, Vietnam
Research Site, Hà Nội, Vietnam
Research Site, Ho Chi Minh City, Vietnam
Research Site, Ho Chi Minh City, Vietnam
Research Site, Huế, Vietnam
Research Site, Vinh, Vietnam
Research Site, Vĩnh Yên, Vietnam Anchorage, United States Est. completion Dec 31, 2026
High Grade Sarcoma Sarcoma
This phase II trial compares standard of care surgical resection to fluorescence-guided surgical resection using indocya…
Duarte, United States Est. completion May 11, 2028